NZ211247A - Controlled release formulation containing bromocriptine - Google Patents
Controlled release formulation containing bromocriptineInfo
- Publication number
- NZ211247A NZ211247A NZ211247A NZ21124785A NZ211247A NZ 211247 A NZ211247 A NZ 211247A NZ 211247 A NZ211247 A NZ 211247A NZ 21124785 A NZ21124785 A NZ 21124785A NZ 211247 A NZ211247 A NZ 211247A
- Authority
- NZ
- New Zealand
- Prior art keywords
- controlled release
- release formulation
- formulation containing
- containing bromocriptine
- bromocriptine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB848405227A GB8405227D0 (en) | 1984-02-29 | 1984-02-29 | Bromocriptine compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ211247A true NZ211247A (en) | 1989-02-24 |
Family
ID=10557324
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ211247A NZ211247A (en) | 1984-02-29 | 1985-02-27 | Controlled release formulation containing bromocriptine |
Country Status (26)
| Country | Link |
|---|---|
| JP (1) | JPS60202812A (es) |
| AT (1) | AT387716B (es) |
| AU (2) | AU586621B2 (es) |
| BE (1) | BE901810A (es) |
| CA (1) | CA1256374A (es) |
| CH (2) | CH666406A5 (es) |
| DE (1) | DE3505743C2 (es) |
| DK (1) | DK175016B1 (es) |
| ES (1) | ES8705223A1 (es) |
| FR (1) | FR2560047B1 (es) |
| GB (1) | GB8405227D0 (es) |
| GR (1) | GR850506B (es) |
| HK (1) | HK85490A (es) |
| HU (1) | HU196121B (es) |
| IE (1) | IE58235B1 (es) |
| IL (1) | IL74459A (es) |
| IT (1) | IT1199948B (es) |
| LU (1) | LU85791A1 (es) |
| MX (1) | MX9203626A (es) |
| NL (1) | NL194231C (es) |
| NZ (1) | NZ211247A (es) |
| PH (1) | PH23266A (es) |
| PT (1) | PT80015B (es) |
| SE (2) | SE462259B (es) |
| SG (1) | SG69390G (es) |
| ZA (1) | ZA851546B (es) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS61501511A (ja) * | 1984-03-21 | 1986-07-24 | アメリカン・ホ−ム・プロダクツ・コ−ポレイション | 徐放性医薬カプセル |
| DE3722383A1 (de) * | 1986-07-14 | 1988-01-28 | Sandoz Ag | Neue verwendung von bromocriptin |
| DE4041563A1 (de) * | 1990-12-22 | 1992-06-25 | Sanol Arznei Schwarz Gmbh | Verfahren zur herstellung wirkstoffhaltiger mikropartikel aus hydrolytisch abbaubaren polymeren |
| US5569450A (en) * | 1993-03-17 | 1996-10-29 | Minnesota Mining And Manufacturing Company | Aerosol formulation containing an ester-, amide-, or mercaptoester-derived dispersing aid |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL265428A (es) * | 1960-06-06 | |||
| CH507249A (de) * | 1968-05-31 | 1971-05-15 | Sandoz Ag | Verfahren zur Herstellung von 2-Brom-a-ergokryptin |
| DE2553026A1 (de) * | 1974-12-04 | 1976-06-10 | Schlueter Edelfett | Neue formulierungen |
| CH630257A5 (en) * | 1975-03-17 | 1982-06-15 | Hoffmann La Roche | Sustained release formulation |
| IT1158162B (it) * | 1977-12-22 | 1987-02-18 | Sandoz Ag | Composizioni farmaceutiche a base di derivati dell'ergolena e dell'ergolina |
| DE3045135A1 (de) * | 1980-11-29 | 1982-06-09 | Sandoz-Patent-GmbH, 7850 Lörrach | Pharmazeutische kompositionen enthaltende bioabbaubare polymere |
| US4369172A (en) * | 1981-12-18 | 1983-01-18 | Forest Laboratories Inc. | Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose |
| DE3216870A1 (de) * | 1982-05-03 | 1983-11-03 | Schering AG, 1000 Berlin und 4709 Bergkamen | Pharmazeutische zubereitungen mit zytostatischer wirkung |
| US4559222A (en) * | 1983-05-04 | 1985-12-17 | Alza Corporation | Matrix composition for transdermal therapeutic system |
-
1983
- 1983-12-14 CH CH6660/83A patent/CH666406A5/de not_active IP Right Cessation
-
1984
- 1984-02-29 GB GB848405227A patent/GB8405227D0/en active Pending
-
1985
- 1985-02-14 NL NL8500417A patent/NL194231C/nl not_active IP Right Cessation
- 1985-02-14 HU HU85555A patent/HU196121B/hu unknown
- 1985-02-20 DE DE3505743A patent/DE3505743C2/de not_active Expired - Lifetime
- 1985-02-20 IT IT47703/85A patent/IT1199948B/it active
- 1985-02-22 CH CH830/85A patent/CH667009A5/de not_active IP Right Cessation
- 1985-02-22 FR FR8502716A patent/FR2560047B1/fr not_active Expired
- 1985-02-25 BE BE1/11199A patent/BE901810A/fr not_active IP Right Cessation
- 1985-02-26 DK DK198500867A patent/DK175016B1/da active Protection Beyond IP Right Term
- 1985-02-26 CA CA000475119A patent/CA1256374A/en not_active Expired
- 1985-02-26 AU AU39136/85A patent/AU586621B2/en not_active Expired
- 1985-02-27 NZ NZ211247A patent/NZ211247A/xx unknown
- 1985-02-27 AT AT0058085A patent/AT387716B/de not_active IP Right Cessation
- 1985-02-27 LU LU85791A patent/LU85791A1/fr unknown
- 1985-02-27 JP JP60040277A patent/JPS60202812A/ja active Granted
- 1985-02-27 IL IL74459A patent/IL74459A/xx not_active IP Right Cessation
- 1985-02-27 SE SE8500961A patent/SE462259B/sv unknown
- 1985-02-27 GR GR850506A patent/GR850506B/el not_active IP Right Cessation
- 1985-02-27 SE SE8500961D patent/SE8500961L/xx not_active Application Discontinuation
- 1985-02-27 PT PT80015A patent/PT80015B/pt unknown
- 1985-02-28 ES ES540807A patent/ES8705223A1/es not_active Expired
- 1985-02-28 ZA ZA851546A patent/ZA851546B/xx unknown
- 1985-02-28 PH PH31923A patent/PH23266A/en unknown
- 1985-02-28 IE IE49585A patent/IE58235B1/en not_active IP Right Cessation
-
1989
- 1989-05-19 AU AU35006/89A patent/AU618599B2/en not_active Expired
-
1990
- 1990-08-22 SG SG693/90A patent/SG69390G/en unknown
- 1990-10-18 HK HK854/90A patent/HK85490A/xx not_active IP Right Cessation
-
1992
- 1992-06-26 MX MX9203626A patent/MX9203626A/es unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3565776D1 (en) | Release devices | |
| GB8526591D0 (en) | Controlled release powder & process | |
| GB2122490B (en) | Controlled release formulation | |
| GB8716323D0 (en) | Bromocriptine | |
| NZ214534A (en) | Sustained release formulation containing theophylline | |
| IL76781A0 (en) | Occular formulation comprising bromocriptine | |
| CY1564A (en) | Bromocriptine compositions | |
| GB8530331D0 (en) | Release means | |
| GB2158159B (en) | Applicator for crease-setting composition | |
| GB8514030D0 (en) | Controlled release iodine | |
| ZA887320B (en) | Can carrier composition | |
| NZ211247A (en) | Controlled release formulation containing bromocriptine | |
| GB8405085D0 (en) | Controlled release formulation | |
| GB8411355D0 (en) | Controlled time release therapeutic composition | |
| ZA853797B (en) | Release devices | |
| GB8521221D0 (en) | Controlled release formulations | |
| ZA856410B (en) | Pest-combating agents containing phosphorus-heterocylic compounds | |
| GB2199774B (en) | Application for crease-setting composition | |
| GB2151137B (en) | Slow release formulations | |
| EP0321786A3 (en) | Composition for external application | |
| IE840461L (en) | Controlled release formulation comprising a¹triazolobenzothiazole | |
| EG17797A (en) | Controlled release formulation | |
| IE863030L (en) | Controlled release composition | |
| GB8421151D0 (en) | Release coating | |
| GB8420729D0 (en) | Release coating |